XML 32 R19.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENT OF ASSETS AND LIABILITIES
9 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENT OF ASSETS AND LIABILITIES FAIR VALUE MEASUREMENT OF ASSETS AND LIABILITIES 
Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. The accounting guidance for fair value establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: 
Level 1 - Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. 
The Company has deferred compensation plans for its officers and certain other employees. Amounts deferred under the plans are invested in hypothetical investments selected by the participant or the participant’s investment manager. The Company’s deferred compensation plan assets are included in other noncurrent assets on the condensed consolidated balance sheets and include investments in equity securities that are valued using active market prices. There were no investments classified as level 1 in the fair value hierarchy as of December 31, 2020 and March 31, 2020. 
Level 2 - Applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets) such as cash and cash equivalents and money market funds; or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. 
The Company values foreign exchange forward contracts using level 2 observable inputs which primarily consist of an income approach based on the present value of the forward rate less the contract rate multiplied by the notional amount. 
The Company’s cash equivalents are comprised of bank time deposits and money market funds, which are valued using level 2 inputs, such as interest rates and maturity periods. Due to their short-term nature, their carrying amount approximates fair value. 
The Company’s deferred compensation plan assets also include money market funds, mutual funds, corporate and government bonds and certain convertible securities that are valued using prices obtained from various pricing sources. These sources price these investments using certain market indices and the performance of these investments in relation to these indices. As a result, the Company has classified these investments as level 2 in the fair value hierarchy. 
Level 3 - Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. 
The Company has accrued for contingent consideration in connection with its business acquisitions as applicable, which is measured at fair value based on certain internal models and unobservable inputs. There were no contingent consideration liabilities outstanding as of December 31, 2020 and March 31, 2020.
There were no transfers between levels in the fair value hierarchy during the nine-month periods ended December 31, 2020 and December 31, 2019. 
Financial Instruments Measured at Fair Value on a Recurring Basis 
The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 and March 31, 2020: 
 Fair Value Measurements as of December 31, 2020
 Level 1Level 2Level 3Total
 (In millions)
Assets:    
Money market funds and time deposits (included in cash and cash equivalents of the condensed consolidated balance sheet)$— $1,755 $— $1,755 
Foreign currency contracts (Note 8)— 108 — 108 
Deferred compensation plan assets:   0
Mutual funds, money market accounts and equity securities— 50 — 50 
Liabilities:   
Foreign currency contracts (Note 8)$— $(39)$— $(39)
 Fair Value Measurements as of March 31, 2020
 Level 1Level 2Level 3Total
 (In millions)
Assets:    
Money market funds and time deposits (included in cash and cash equivalents of the condensed consolidated balance sheet)$— $404 $— $404 
Foreign currency contracts (Note 8)— 104 — 104 
Deferred compensation plan assets:   0
Mutual funds, money market accounts and equity securities— 49 — 49 
Liabilities:   0
Foreign currency contracts (Note 8)$— $(149)$— $(149)
Other financial instruments 
The following table presents the Company’s major debts not carried at fair value: 
 As of December 31, 2020As of March 31, 2020
 Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Fair Value
Hierarchy
 (In millions)
Term Loan, including current portion, due in installments through June 2022$— $— $433 $414 Level 1
5.000% Notes due February 2023
500 541 500 500 Level 1
Term Loan due April 2024 - three-month Yen LIBOR plus 0.500%
324 324 310 310 Level 2
4.750% Notes due June 2025
598 680 597 613 Level 1
3.750% Notes due February 2026
695 771 — — Level 1
4.875% Notes due June 2029
661 786 662 628 Level 1
4.875% Notes due May 2030
696 826 — — Level 1
Euro Term Loans175 175 208 208 Level 2
India Facilities136 136 138 138 Level 2
The Term Loan due June 2022, and the Notes due February 2023, June 2025, February 2026, June 2029 and May 2030 are valued based on broker trading prices in active markets. 
The Company values its Term Loan due April 2024, India Facilities, and Euro Term Loans due March 2021 and January 2022 based on the current market rate, and as of December 31, 2020, the carrying amounts approximate fair values.